CD19 and leukemia: In the xenograft study of NSG mice bearing Nalm6 leukemia cells expressing GFP, we demonstrated that mice treated with anti-CD19 CART-aIL6/IL1RA with GM-CSF/TCR KO significantly prolonged survival by completely eliminating leukemia cells (Fig. 2i).